Institutional Holders (2026 Q2)
287 + investorsExplore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BHVN. Verified SEC 13F-HR filings.
| # | Investor | % of Portfolio | Shares | Mkt Value |
|---|---|---|---|---|
| 1 | Royalty Pharma Sub-Manager, LLC | 18.06% | 2,936,507 | $43.7M |
| 2 | Infinitum Asset Management, LLC | 9.46% | 6,250,000 | $93.0M |
| 3 | Sarissa Capital Management LP | 4.87% | 582,312 | $8.7M |
| 4 | Pfizer Inc | 4.70% | 505,645 | $8.0M |
| 5 | 5AM Venture Management, LLC | 3.82% | 738,972 | $11.0M |
| 6 | Lion Point Capital, LP | 3.68% | 51,700 | $769K |
| 7 | Montanova Capital, LLC | 2.80% | 10,286,937 | $153.1M |
| 8 | Stempoint Capital LP | 2.73% | 1,064,200 | $15.8M |
| 9 | MYDA Advisors LLC | 2.55% | 1,150,000 | $17.1M |
| 10 | Cormorant Asset Management, LP | 1.99% | 2,610,000 | $38.8M |
| 11 | QTR Family Wealth, LLC | 1.75% | 337,432 | $5.0M |
| 12 | Ikarian Capital, LLC | 1.20% | 748,181 | $11.1M |
| 13 | ARS Investment Partners, LLC | 0.89% | 1,374,185 | $20.4M |
| 14 | TCG Crossover Management, LLC | 0.64% | 1,779,952 | $26.5M |
| 15 | Diadema Partners LP | 0.60% | 317,000 | $4.7M |
| 16 | Kennondale Capital Management LLC | 0.52% | 52,693 | $784K |
| 17 | Integral Health Asset Management, LLC | 0.41% | 700,000 | $10.4M |
| 18 | Eversept Partners, LP | 0.40% | 515,804 | $7.7M |
| 19 | DAFNA Capital Management LLC | 0.39% | 137,593 | $2.0M |
| 20 | DCF Advisers, LLC | 0.35% | 134,500 | $2.0M |
| 21 | Woodline Partners LP | 0.35% | 7,660,280 | $114.0M |
| 22 | DCF Advisers, LLC | 0.34% | 130,000 | $1.9M |
| 23 | ADAR1 Capital Management, LLC | 0.34% | 501,687 | $7.5M |
| 24 | Sphera Funds Management LTD. | 0.32% | 164,437 | $2.4M |
| 25 | QVT Financial LP | 0.31% | 354,206 | $5.3M |
| Investor | Ownership History |
% of Portfolio | Prev % | Rank | Conviction | Avg Buy Price | 13F Score™ 3Y / 7Y | Sell Timing | Shares | Mkt Value | Change | Change % | Source | Quarter | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|